Kamala Harris a COVID-19 vaccine before the election: “I would not trust Donald Trump”


Democratic vice-presidential candidate Kamala Harris said she would not trust President Trump’s word on the effectiveness of a coronavirus vaccine, in an interview due to air on Sunday.

Harris has raised concerns that medical professionals would not be the ones to validate a vaccine if it is rejected before the Nov. 3 election.

« [T]hey will be muzzled, they will be removed, they will be sidelined, because he is looking at an election in less than 60 days, and he is taking everything he can get to pretend he has been a leader on this question when it’s not, ”Harris said in the CNN interview.

“I will say that I would not trust Donald Trump and that it would have to be a credible source of information that talks about the effectiveness and reliability of everything he talks about,” she added. .


Reports from Food and Drug Administration (FDA) officials feeling pressure to produce a vaccine as soon as possible surfaced earlier this week in a CNN article. The Trump administration has also asked states to prepare vaccine distribution sites by November 1 – even though the FDA has yet to approve a vaccine.

“This timeline of the initial deployment at the end of October is deeply concerning for the politicization of public health and the potential ramifications of security,” infection prevention epidemiologist Saskia Popescu told The New York Times. early this week.

A letter sent by the Centers of Disease Control and Prevention (CDC) called for states to consider “waiving requirements” that could prevent vaccine distribution facilities from being fully operational by November 1, the report said. Wall Street Journal. This decision is increasingly worrying healthcare professionals, as the vaccine has not yet completed phase III clinical trials.

FDA commissioner Stephen Hahn was also criticized last week for information he provided on an experimental coronavirus treatment solution using blood plasma, during a press conference with Trump.

Hahn said that with the new therapy, 35 out of 100 people who died from coronvairus could have been saved. But the statement turned out to be incorrect because it did not assess variables for the entire study. Nonetheless, it has become a topic of discussion for the Trump administration.

Hahn said in an interview with Bloomberg after the presser, that he should have been more careful.

“I was trying to do what I do with patients because patients often understand things in absolute terms rather than in relative terms,” he said.

“What I was trying to do is if you look at 100 patients who received a high titer and 100 patients who received a low titer, the difference between those two particular subgroups of patients who met those criteria. specific was a 35% reduction in mortality. Hahn explained. “So frankly I haven’t done a good job of explaining this. ”


Trump has repeatedly said he believes a vaccine will be released before the end of the year, and potentially by the end of October – days before Americans go to the polls for the general election.

“It will be delivered before the end of the year, in my opinion, before the end of the year, but it could even be delivered before the end of October,” Trump said at a rally Thursday. “How do you like it?” Wouldn’t that be nice? And you know why? Not because of the elections. It would be good because we want to save people. ”

Despite concerns from opponents of Trump and some health care experts, Dr Anthony Fauci, an infectious disease expert who sits on the White House Coronavirus Task Force said in an interview with Kaiser Health News earlier this week, that phase three of the clinical trials had the potential to end earlier than expected, if the results turn out to be overwhelmingly positive.

Fauci told the publication that the Data and Safety Oversight Committee could say, “The data is so good right now that you can say it is safe and efficient.”

The country’s leading infectious disease doctor said the council had a “moral obligation” to end the trial if the results were significant.


“If you are making a decision on the vaccine, you had better make sure you have very good evidence that it is both safe and effective,” Fauci said.

“I am not concerned about political pressure,” he added.

Although even if a vaccine were safely distributed in states nationwide, as many as a third of all Americans said they would refuse a vaccination even if it was readily available – showing yet another hurdle in overcoming the coronavirus.


Please enter your comment!
Please enter your name here